Neogenomics Inc header image

Neogenomics Inc

NEO

Equity

ISIN null / Valor 1589606

NASDAQ (2026-11-17)
USD 15.25-1.04%

Neogenomics Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

NeoGenomics Inc is a specialized laboratory and diagnostics company with a primary focus on cancer-related services. For over 18 years, it has been at the forefront of providing comprehensive testing and analysis for cancer diagnostics and clinical trials. The company operates on a global scale, employing a diverse team of professionals including physicians, scientists, and laboratory experts. These professionals collaborate closely with cancer care teams to offer critical oncological insights, aiming to significantly improve patient outcomes. NeoGenomics positions itself as a key player in the oncology sector by offering a range of services tailored to meet the needs of oncologists, pathologists, pharmaceutical companies, and academic institutions. Its offerings encompass diagnostic services, pharmaceutical services, and information services, all designed to facilitate the advancement of cancer care and treatment. Through its dedication to innovation and patient care, NeoGenomics strives to contribute to the development of new and improved cancer therapies, thereby enhancing the quality of life for those affected by cancer.

Summarized from source with an LLMView SourceSector: Finance

Latest Results ():

Summarized from source with an LLMView Source

Key figures

49.2%1Y
-21.4%3Y
-62.5%5Y

Performance

53.3%1Y
65.5%3Y
71.1%5Y

Volatility

Market cap

1973 M

Market cap (USD)

Daily traded volume (Shares)

1,033,367

Daily traded volume (Shares)

1 day high/low

16.95 / 16.39

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Frey SA
Frey SA Frey SA Valor: 3887445
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 33.80
First Interstate Bancsystem Inc
First Interstate Bancsystem Inc First Interstate Bancsystem Inc Valor: 11165896
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.73%USD 36.75
Indian Overseas Bank
Indian Overseas Bank Indian Overseas Bank Valor: 1168259
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.67%INR 31.69
UCO Bank
UCO Bank UCO Bank Valor: 1670473
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.81%INR 24.88
Capri Global Capital Limited
Capri Global Capital Limited Capri Global Capital Limited Valor: 133292633
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.64%INR 240.15
KE Holdings Inc
KE Holdings Inc KE Holdings Inc Valor: 56518458
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.23%USD 18.41
Poonawalla Fincorp Limited
Poonawalla Fincorp Limited Poonawalla Fincorp Limited Valor: 11552463
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%INR 488.95
Choice International Limited
Choice International Limited Choice International Limited Valor: 1127462
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.28%INR 726.40
Sammaan Capital Ltd
Sammaan Capital Ltd Sammaan Capital Ltd Valor: 18511774
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.44%INR 131.15
Commerce Bancshares Inc
Commerce Bancshares Inc Commerce Bancshares Inc Valor: 919912
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.77%USD 54.53